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Calcium current through voltage-gated calcium channels (VGCC) controls gene 
expression. Here, we describe a novel signaling pathway in which the VGCC 
Cacnb4 subunit directly couples neuronal excitability to transcription. Electrical 
activity induces Cacnb4 association to Ppp2r5d, a regulatory subunit of PP2A 
phosphatase, followed by i) nuclear translocation of Cacnb4/Ppp2r5d/PP2A, ii) 
association with the tyrosine hydroxylase (TH) gene promoter through the nuclear 
transcription factor thyroid hormone receptor alpha (TRα), and iii) histone binding 
through association of Cacnb4 with HP1γ concomitantly with Ser10 histone H3 
dephosphorylation by PP2A. This signaling cascade leads to TH gene repression by 
Cacnb4 and is controlled by the state of interaction between the SH3 and guanylate 
kinase (GK) modules of Cacnb4. The human R482X CACNB4 mutation, 
responsible for a form of juvenile myoclonic epilepsy, prevents association with 
Ppp2r5 and nuclear targeting of the complex by altering Cacnb4 conformation. 
These findings demonstrate that an intact VGCC subunit acts as a repressor 
recruiting platform to control neuronal gene expression. 
Keywords: β4 subunit / Gene regulation / thyroid receptor alpha / phosphatase 2A / HP1γ 
 
Introduction 
Voltage-gated calcium channels (VGCC) are heteromultimeric complexes that 
translate electric signals into calcium influx (Catterall et al, 2005), thereby controlling 
synaptic vesicle exocytosis, neuronal excitability and gene expression (Deisseroth et al, 
2003; Flavell & Greenberg, 2008; Greer & Greenberg, 2008). In VGCC, the pore-
forming subunit is associated to auxiliary subunits, among which the cytoplasmic Cacnb4 
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(β4) plays an essential function in channel expression level at the plasma membrane and 
biophysical properties (Arikkath & Campbell, 2003). Mutations in the genes encoding 
VGCC induce diverse neuronal pathologies, such as epilepsy, ataxia, autism, and 
migraine (Bidaud et al, 2006). In humans, a mutation of CACNB4, leading to a 38 amino 
acid truncation of β4 C-terminus, has been associated to juvenile myoclonic epilepsy 
(Escayg et al, 2000). In mice, a four-nucleotide insertion into a splice donor site of 
Cacnb4 results in a truncation of 60% of the protein sequence and a lethargic (lh) 
phenotype (Burgess et al, 1997). How these mutations may affect VGCC-mediated 
function still remains an open question. Calcium entering through VGCC has been 
implicated in gene regulation by activating calcium-binding proteins that propagate the 
signal to the nucleus (Dolmetsch et al, 2001; Graef et al, 1999; Oliveria et al, 2007; 
Rosen et al, 1994) or by diffusing to the nucleus with or without signal amplification by 
intracellular stores (Carrion et al, 1999; Hardingham et al, 2001; Hardingham et al, 
1997). Evidences for alternative pathways have been reported. First, an atypical short β4 
splice variant, β4c, was shown to interact with heterochromatin protein 1 gamma (HP1γ), 
a nuclear protein involved in gene silencing and transcription regulation (Hibino et al, 
2003; Xu et al, 2011). However, β4c lacks the domain required for association with the 
pore subunit (Chen et al, 2004) and therefore cannot couple neuronal activity to gene 
regulation. A second pathway implicates CCAT, a C-terminal fragment of Cacna1c 
VGCC, as a calcium-regulated transcription factor (Gomez-Ospina et al, 2006). In this 
case, calcium influx triggers CCAT nuclear export providing a calcium-dependent link 
between neuronal activity and transcription. The origin of this fragment (channel 
proteolysis or alternative splicing) remains unknown. 
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Here, we show that β4 directly couples neuronal excitability to gene expression 
along a signaling pathway that is disrupted by the human R482X mutation. We found that 
electrical activity promotes the formation of a new nuclear complex in which β4 plays the 
role of an organizing platform that brings together a transcription factor for DNA 
binding, a phosphatase for histone dephosphorylation and HP1γ for nucleosome 
association. Formation of this complex controls gene activity as witnessed by the case of 
tyrosine hydroxylase (TH) gene. 
 
Results 
β4 nuclear localization 
β4 is highly expressed in the hippocampal dentate gyrus of adult wild-type (wt) C57Bl/6 
mice brain but not in lh mice brain (Figure 1a). β4 labeling is strongest in soma and 
coincides with NeuN nuclear labeling, suggesting that a fraction of β4 protein may be 
localized in cell nuclei, in agreement with previous observations (Subramanyam et al, 
2009). Western blot analyses of wt brain lysates show a unique 58 kDa band, 
corresponding to β4, absent in lh (Figure 1b). Western blot analyses of cytoplasmic 
versus nuclear fractions of wt brain lysates show the presence of β4 in the nucleus (Figure 
1c). Electron microscopy (EM) demonstrates the presence of β4 in the nucleus of CA1 
hippocampal neurons (Figure 1d & Supplementary Figure 1). In primary cultures of 
hippocampal neurons, β4 is predominantly expressed within the cytoplasm/plasma 
membrane at 5 DIV (Figure 1e, left panels). In contrast, the protein is densely located in 
the nucleus at 18 DIV (Figure 1e, right panels). The nuclear to cytoplasmic density ratios 
(NCR values) of β4 increases as a function of time from 0.07 (3 DIV) to 3.81 (18 DIV) on 
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average indicating the differentiation-dependent progressive targeting of β4 to neuronal 
nuclei (Figure 1f). NCR value increase is accompanied by a histogram broadening 
witnessing higher β4 subcellular distribution variability among neurons. β4 nuclear 
appearance coincides with that of VGCC currents and electrical activity at 5 DIV 
(unpublished observation). EM analysis of hippocampal neurons at 5 and 18 DIV also 
illustrate the increase of β4 nuclear density at 18 DIV (Figure 1g). Synchronized neuronal 
differentiation of NG108-15 cells, induced by serum deprivation and 1 mM cAMP, is 
accompanied by VGCC expression (Chemin et al, 2002). In undifferentiated NG108.15 
cells, β4 is exclusively cytoplasmic, while present in nuclei after 13 days of 
differentiation (Figure 1h). Mean NCR values illustrate that nuclear β4 expression is 
triggered by neuronal differentiation (Figure 1i). 
 
β4 epilepsy mutation alters nuclear targeting 
To search for a β4 nuclear targeting domain, truncated β4-EGFP constructs were 
expressed in CHO cells (Figure 2a). In CHO and HEK293 cells, β4-EGFP spontaneously 
locates in the nucleus (NCR = 10.1 ± 3.3 for CHO cells). In contrast, truncated constructs 
are deficient in nuclear targeting suggesting that β4 has no nuclear localization sequence 
(NLS) or that the NLS sequence depends on β4 structure integrity (Figure 2b,c). Indeed, 
five constructs display a distribution similar to EGFP alone (NCR ~1). Two constructs, 
that contain β4 guanylate kinase (GK) domain, show preferential cytoplasm distribution 
(NCR = 0.27 ± 0.2 and 0.26 ± 0.2 for β216-402-EGFP and β216-519-EGFP, respectively). β4-
EGFP truncation therefore results in 10 to 40-fold decrease of nuclear targeting 
efficiency. These data were confirmed for two truncated β4 constructs by Western blot 
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analyses of nuclear and cytoplasmic fractions of transfected HEK293 cells 
(Supplementary Figure 2a). An earlier report mentioned the importance of a restricted N-
terminal domain for β4 nuclear accumulation (Subramanyam et al, 2009). As observed in 
this study, mutation of this domain significantly reduced nuclear accumulation albeit by a 
limited extent (by 1.41-fold, from a mean NCR value of 11.4 ± 0.7 to 8.1 ± 0.7). 
However, βR28A-R29A-S30A-EGFP still significantly accumulates into the nucleus in contrast 
to the constructs presented in this manuscript. 
We engineered a β1-481-EGFP mutant (Figure 2a) corresponding to the human 
juvenile myoclonic epilepsy mutation (Escayg et al, 2000) and assessed its cellular 
distribution in CHO cells (Figure 2b,c). Nuclear accumulation of β1-481-EGFP mutant is 
strongly reduced (NCR = 0.98 ± 0.62; 10.3-fold lower than β4-EGFP NCR). This 
mutation induces a loss in nuclear targeting as shown by Western blot analyses of nuclear 
and cytoplasmic fractions of CHO cells (Figure 2d). Finally, β1-481-EGFP mutant is 
completely excluded from hippocampal neuron nuclei at 7 DIV (NCR = 0.32 ± 0.18; 
Figure 2e,f). This corresponds to a 9.5-fold decrease in NCR value compared to β4-EGFP 
(3.15 ± 1.76), a reduction similar to that measured in CHO cells. Double imaging of 
immunolabeled endogenous β4 and β1-481-EGFP indicates the extent of nuclear exclusion 
of the mutant (Figure 2g). In conclusion, the nuclear targeting of β4 requires the 
preservation of its structural integrity. The human epilepsy mutation alters this structural 
integrity and hinders nuclear targeting. 
 
The SH3/GK interaction controls β4 nuclear targeting 
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Interaction between β SH3 and GK domains regulates channel activity (McGee et al, 
2004; Takahashi et al, 2005). Its role was therefore investigated on β4 nuclear targeting. 
Three constructs were designed: β1-166-EGFP, β200-519-myc, and β200-481-myc 
(corresponding to the juvenile epilepsy deletion) (Figure 3a). In agreement with Figure 
2c, none of these constructs show a specific nuclear targeting in CHO cells (Figure 3b). 
Expressed together, β1-166-EGFP and β200-519-myc reconstitute a nuclear-targeting-
competent complex (Figure 3c; NCR = 6.9 ± 1.6 for β1-166-EGFP, and 7.1 ± 1.1 for β200-
519-myc). In contrast, expression of β1-166-EGFP with β200-481-myc fails to form a nuclear 
complex (Figure 3c, right panels). Co-immunoprecipitation experiments show that β200-
481-myc no longer interacts with β1-166-EGFP contrary to β200-519-myc (Figure 3d). These 
data suggest that the human mutation prevents β4 nuclear targeting by modulating the 
SH3/GK interaction. This issue was further addressed by investigating the effect of two 
mutations (SH3 L125P or GK P225R) known to disrupt the SH3/GK interaction (McGee 
et al, 2004; Takahashi et al, 2004) (Figure 3e). As shown, β1-166-L125P-EGFP no longer 
interacts with β200-519-myc (Figure 3f). Also, both βL125P-EGFP and βP225R-EGFP are 
completely excluded from hippocampal neuron nuclei (Figure 3g). NCR values, 0.43 ± 
0.15 (L125P) and 0.43 ± 0.11 (P225R), correspond to a 7.3-fold decrease in mutant β4 
nuclear localization (Figure 3h). These results demonstrate that β4 nuclear targeting 
requires the internal SH3/GK and reveal a previously unrecognized structural role of the 
last C-terminal 38 amino acid sequence in modulating the interaction between the C-
terminal containing hemi-β4 subunit and the SH3-containing β4 fragment. 
 
The phosphatase 2A Ppp2r5d (B56δ) subunit contributes to β4 nuclear localization 
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Absence of a clear molecular determinant for β4 nuclear targeting, suggests that this 
process requires at least one protein partner, whereas defective β1-481, βL125P and βP225R 
nuclear localization indicates that interaction with this (these) partners depends on 
SH3/GK interaction state. Yeast two-hybrid screenings were performed with a mouse 
brain complementary DNA library using β4 as bait. The 62 positive clones were subjected 
to two-hybrid β-galactosidase assays using β4 and β1-481 as baits. B56δ, a 594 amino acid 
protein containing a poorly-defined NLS at its C-terminus, was revealed to interact with 
β4 but not with β1-481 (Figure 4a). B56δ is one of the two regulatory subunits of 
phosphatase 2A (PP2A), along with B56γ, known to target PP2A to the nucleus 
(McCright et al, 1996). Co-immunoprecipitation confirms that β4-EGFP, but not β1-481-
EGFP, interacts with B56δ-myc expressed in HEK293 cells (Figure 4b). As expected, 
Cacna1e and RIM1 were also identified as β4 partners (Kiyonaka et al, 2007). In contrast 
to B56δ, both proteins interact equally well with β4 and β1-481. These yeast two-hybrid 
assays also reveal that Cacnb3 (β3), another β isoform, also interacts with B56δ 
suggesting the existence of redundant signaling pathways (Figure 4c). β4c, a short β4 
splice variant, known to interact with the HP1γ chromo shadow domain (Hibino et al, 
2003), does not interact with B56δ. Conversely, β4 does not interact with HP1γ in these 
conditions (Figure 4c). Truncated β4 constructs were analyzed for B56δ interaction by 
yeast two-hybrid assays (Figure 4d). β49-519 is the only truncated construct interacting 
with B56δ indicating that the N-terminus is not essential for this interaction. B56δ does 
not interact with βL125P confirming that binding to β4 requires an intact SH3/GK 
interaction (Figure 4d). Endogenous B56δ is expressed in both HEK293 and CHO cells 
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in agreement with spontaneous nuclear targeting of β4 (Supplementary Figure 3a,b). 
Exogenous B56δ-myc co-localizes with nuclear β4-EGFP and further increases β4-EGFP 
nuclear targeting in CHO cells (Supplementary Figure 3c). Conversely, expression of a 
B56δ shRNA, reducing the level of endogenous B56δ in CHO cells (Supplementary 
Figure 3b), leads to a reduction of β4-EGFP nuclear targeting (NCR value dropping from 
11.5 ± 0.7 to 7.3 ± 0.5 or average 4.3-fold redistribution between nuclear and cytoplasmic 
pools by WB) (Figure 4e,f). In agreement with binding data, B56δ-myc expression has no 
effect on β1-481-EGFP distribution in CHO cells (Supplementary Figure 3d). Expression 
of B56δ-myc in non-differentiated NG108-15 cells produces a marked nuclear re-
localization of endogenous β4 (Figure 4g; 11.8-fold increase in NCR). The influence of 
B56δ on endogenous β4 nuclear localization was further investigated using B56δ-/- mice 
(Louis et al, 2011). Hippocampal neurons from B56δ-/- mice show a significant 1.65-fold 
decrease in NCR value at 11 DIV (Figure 4h). Similarly, the density of immunogold-
labeled endogenous β4 is significantly decreased by 1.61-fold in B56δ-/- adult 
hippocampal neurons compared to wt hippocampal neurons (Figure 4i). In conclusion, 
B56δ is a SH3/GK conformation-sensitive β4 partner that contributes to nuclear 
distribution of β4. Since a fraction of β4 is still nuclear in the absence B56δ, we conclude 
that other B56 isoforms and/or nuclear partners also help β4 accumulation in neuronal 
nuclei. β1-481 deficient nuclear targeting originates from its inability to interact with B56δ. 
 
β4 forms a complex with B56δ and active PP2A 
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Immunoprecipitation of endogenous β4 from wt mice brain results in coprecipitation of 
B56δ and PP2A (Figure 5a). As expected, neither B56δ nor PP2A are 
immunoprecipitated from lh mice brain by β4 antibodies. Similarly, PP2A is not 
precipitated by β4 antibodies using B56δ-/- mice brain indicating that PP2A/β4 association 
requires B56δ. In HEK293 cells, over-expression of B56δ-EGFP with β4-myc strongly 
enhances endogenous PP2A immunoprecipitation through β4-myc (Figure 5b). Restricted 
immunoprecipitation of endogenous PP2A by antibodies against β4-myc suggests that not 
all endogenous B56δ (Supplementary Figure 3a) is associated to PP2A in these cells, 
possibly due to a competition with other B regulatory isoforms unable to associate to β4-
myc. As expected, β1-481-myc mutant does not precipitate endogenous PP2A in the 
presence of B56δ-EGFP (Figure 5b). β4-myc/B56δ-EGFP complex immunoprecipitated 
from HEK293 cells shows PP2A phosphatase activity (Figure 5c). 
 
Membrane depolarization triggers β4 association to B56δ 
β4-EGFP, expressed together with Cacna1a and Cacna2d2, pore-forming and auxiliary 
subunits of VGCC, loses its nuclear distribution in HEK293 cells (Figure 5d, NCR = 0.25 
± 0.1, i.e. 40-fold reduction). Part of β4-EGFP staining is cytoplasmic instead of at the 
plasma membrane, possibly by interaction with Cacna1a stuck in the endoplasmic 
reticulum. As expected, β1-481-EGFP mutant distribution remains cytoplasmic in the 
presence of VGCC (Figure 5d, right panel). In the presence of Cacna1a and Cacna2d2, 
B56δ-myc no longer interacts with β4-EGFP (Figure 5e). These data indicate that (i) 
B56δ does not form a higher order molecular complex with the channel and (ii) β4 
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association to Cacna1a overrides its interaction with B56δ. In addition, B56δ-EGFP does 
not affect VGCC kinetics and current densities in HEK293 cells (Supplementary Figure 
4a,b). Also, Ca2+ currents were not modified in hippocampal neurons from B56δ-/- mice 
(Supplementary Figure 4c,d), confirming that B56δ does not associate to the channel 
complex. Previous reports evidenced that β/channel interaction is reversible (Restituito et 
al, 2001; Sandoz et al, 2004; Spafford et al, 2004), but the impact of membrane 
depolarization on this interaction has not been studied. Membrane depolarization of 
HEK293 cells enhances β4-myc interaction with B56δ-EGFP, while it does not promote 
any interaction between β1-481-myc and B56δ-EGFP (Figure 5f). In the presence of 
VGCC, the depolarization-induced B56δ-myc/β4-EGFP interaction requires external Ca2+ 
(Supplementary Figure 5). In these conditions, β4-myc precipitates endogenous PP2A 
only upon membrane depolarization (Figure 5g). In contrast, β1-481-myc does not 
precipitate PP2A upon depolarization. Finally, blocking electrical activity of 11 DIV 
hippocampal neurons by 1 µM tetrodotoxin (TTX) produces a significant 2.1-fold 
reduction of β4 NCR value measured at 18 DIV (Figure 5h). This TTX effect is not 
observed in B56δ-/- hippocampal neurons, demonstrating that β4 nuclear accumulation 
induced by electrical activity relies on B56δ. Note the 2.45-fold reduction in NCR value 
between wt and B56δ-/- control neurons at 18 DIV in agreement with B56δ role in β4 
nuclear accumulation. Conversely, a 1 hr stimulation of neuronal electric activity by a 
biccuculine/4-AP cocktail produces a significant 23.5 ± 1.9% increase in NCR value that 
is not observed in B56δ-/- hippocampal neurons (Figure 5i). Depolarization of the plasma 
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membrane therefore represents an important signaling event that allows β4/B56δ 
interaction and favors β4 nuclear accumulation. 
 
β4 represses TH gene expression by interacting with the thyroid hormone receptor 
alpha 
To determine whether β4 regulates transcription of endogenous genes, we analyzed a 
publicly available microarray data set comparing gene expression in wt and lh mice 
cerebellum (data set GSE6275 from Gene Expression Omnibus, 
http://www.ncbi.nlm.nih.gov/geo). A volcano plot representation of our statistical 
analysis identifies 56 up-regulated and 38 down-regulated genes (over twofold expression 
change, p<0.05) in lh mice cerebellum (Supplementary Figure 6). Based on gene 
ontology annotations, clustering of regulated transcripts in functional groups illustrate 
that many encode proteins with functions related to signaling and ion transport 
(Supplementary Figure 6). Among these genes, those coding for TH and for BC031748 
cDNA sequence are the most up- and down-regulated, respectively (Figure 6a). The 
effect of β4 on gene expression was confirmed on a set of genes by qRT-PCR 
experiments using purified mRNA from wt and lh mice cerebellum (Figure 6b). From 
both approaches, TH gene shows the greatest variation in expression level; an interesting 
observation considering its relevance in epilepsy (Bengzon et al, 1999; Donato et al, 
2006; Hess & Wilson, 1991). The up-regulation of TH expression in lh mice cerebellum 
indicates that β4 acts as a repressor on this gene. Transcripts up- or down-regulation is 
lost in the hippocampus and in the cortex indicating the existence of compensatory 
mechanisms to the lack of β4. Interaction of β4 with the promoter region of TH gene was 
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investigated by chromatin immunoprecipitation (ChIP) experiments. ChIP of the TH gene 
promoter from hippocampal neurons in culture, using antibodies against β4, shows 
specific precipitation at 18 DIV but not 1 DIV (Figure 6c). As a control, ChIP of the 3’-
UTR region of TH gene were negative at 18 DIV. Similar results were obtained for ChIP 
experiments of the transmembrane protein 100 gene promoter (Supplementary Figure 7), 
suggesting that the TH promoter is not an isolated case. In wt mice brain, β4 antibodies 
immunoprecipitate 1.89 ± 0.42% of TH promoter input, corresponding to a 6.3-fold 
enrichment over control (Figure 6d). In contrast, no specific TH promoter 
immunoprecipitation is observed using lh mice brain (Figure 6d). β4 antibodies also 
immunoprecipitate 1.37 ± 0.06% of TH promoter from B56δ-/- mice, indicating that β4 
association with the promoter does not necessarily require the B56δ partner (3.3-fold 
enrichment; Supplementary Figure 8a). Yeast two hybrid screening, using β4 as bait, was 
used to identify a transcription factor that targets β4 to the TH gene. The thyroid hormone 
receptor alpha (TRα) came out as a positive candidate (Figure 6e). TRα is a nuclear 
receptor that contains a T3 hormone binding domain and a DNA binding domain 
interacting with Thyroid Receptor Elements (TRE). Interaction of TRα with β4 was 
confirmed by coimmunoprecipitation experiments in HEK293 cells (Figure 6f). 
However, this interaction is barely detectable in wt brain lysates probably because it 
constitutes a minor interacting fraction of total brain β4 (not shown). ChIP using TRα 
antibodies show that TRα can interact with the TH gene promoter regardless of the 
presence of β4 or B56δ (Figure 6g). Enrichments of the TH gene promoter were 4.92-, 
4.77- and 4.27-fold for wt, lh and B56δ KO brains, respectively. This result is in 
agreement with the presence of putative TRE in the promoter region and in the coding 
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sequence of the TH gene. The effect of TRα on TH gene promoter was tested using a 
luciferase reporter (Figure 6h). TRα has little effect on its own on the expression of 
luciferase, while its activation by the T3 hormone leads to a 4.4-fold repression of 
luciferase expression (Figure 6h). Interestingly, β4, like T3, activates the repressing 
function of TRα (4.8-fold repression). The effect of β4 on TRα activity may therefore 
constitute a first step of TH gene repression in agreement with the up-regulation of this 
gene in the cerebellum in the absence of β4. 
 
B56δ induces the recruitment of HP1γ by β4 and contributes to association of the 
signaling complex with histones 
ChIP experiments using B56δ antibodies reveal the presence of B56δ within the β4 
complex associated to the promoter of the TH gene (Figure 7a). Control experiments 
using B56δ KO mice brain demonstrate the specificity of the signal, while the absence of 
TH precipitation in lh brain denotes a key role of β4 in targeting B56δ to the TH 
promoter. The presence of PP2A in the complex associated to the TH promoter was also 
confirmed by using PP2A antibodies (Figure 7b). TH promoter precipitation by PP2A 
antibodies was diminished in lh brain indicating the importance of β4 in recruiting PP2A 
to the TH gene (Supplementary Figure 8b). Next, we questioned the role of B56δ and 
PP2A in TH gene regulation. Phosphorylation of histones regulates chromatin state and 
gene transcription (Jenuwein & Allis, 2001). Within the nucleus of wt CA1 hippocampal 
neurons, 45% of β4 gold-labeled is associated to heterochromatin (black arrows; 
n=195/440, Figure 1d), whereas the remaining fraction is associated to euchromatin. 
Expression of B56δ-EGFP together with β4-myc in HEK293 cells leads to a genome-
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wide dephosphorylation of Ser10 of histone H3 (Figure 7c), in agreement with earlier 
findings that PP2A dephosphorylates histone H3 (Nowak et al, 2003). This effect cannot 
be attributed to an increased population of transfected cells in G2/M phases of the cell 
cycle (Supplementary Figure 8c). In addition, immunoprecipitated β4-myc/B56δ-
EGFP/PP2A-HA complex allows dephosphorylation of a Ser10 phosphorylated histone 
H3 N-terminal peptide (Figure 7d). Finally, ChIP experiments using anti-histone H3 and 
anti-phosphorylated H3 Ser10 antibodies shows that the absence of β4 in lh brain is 
accompanied by an increase of histone H3 Ser10 phosphorylation at the TH promoter 
(Figure 7e). Ser10 dephosphorylation of histone H3 has been associated to recruitment of 
HP1γ (Fischle et al, 2005). Interestingly, HP1γ has been shown to interact with a PXVXV 
motif on β4c (Xu et al, 2011), a short splice variant of β4. Although this motif is also 
found in full length β4 (Figure 7f), no interaction with HP1γ has been detected by yeast 
two hybrid (Figure 4c and ref. (Hibino et al, 2003)). Nevertheless, we questioned whether 
the interaction of β4 with B56δ could control its interaction with HP1γ. Indeed, 
expression of B56δ-EGFP strongly enhances immunoprecipitation of HP1γ-EGFP by β4-
myc (Figure 7g). The basal level of precipitation of HP1γ-EGFP by β4-myc is due to the 
presence of endogenous B56δ in HEK293 cells (Supplementary Figure 3a). The B56δ-
dependence of HP1γ/β4 interaction, together with the PP2A-induced dephosphorylation 
of histone H3 Ser10, prompted us to investigate the interaction of this complex with 
histones. Immunoprecipitation of mice brain β4 leads to the precipitation of histone H3 
(Figure 7h). The specificity of this association is witnessed by the lack of histone H3 
precipitation from lh brain. Importantly, β4 association with histone H3 is lost in B56δ-/- 
mice brain, in agreement with the specific role of B56δ in β4/HP1γ interaction. In 
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HEK293 cells, immunoprecipitation of β4-myc leads to the co-precipitation of all 
histones (H2B, H3 and H4) (Figure 7i), constitutive of nucleosomes. This is in agreement 
with the endogenous expression of B56δ (Supplementary Figure 3a) and HP1γ 
(Supplementary Figure 3d) in these cells. Expression of B56δ further enhances β4-
myc/histone interaction (Figure 7i). Similarly, B56δ-myc requires the expression of β4-
EGFP to precipitate histone H3, in agreement with the fact that HP1γ binds β4 and not 
B56δ (Figure 7j). B56δ-myc expressed together with βL125P-EGFP or β1-481-EGFP 
mutants, deficient for B56δ association, no longer precipitate histone H4 further 
supporting the B56δ-dependence of β4/HP1γ interaction (Figure 7k). Neuronal 
differentiation strongly increases the association of endogenous β4 with histone H3 in 
NG108-15 (Supplementary Figure 9a), which correlates with the differentiation-
dependent β4 nuclear targeting (Figure 1h,i). In the presence of B56δ-EGFP and channel 
subunits, membrane depolarization increases β4-myc, but not β1-481-myc, association to 
histone H3 (Supplementary Figure 9b). Coherent with its role as PP2A regulatory subunit 
and its genome-wide effect observed in Figure 7c, B56δ-EGFP expression in HEK293 
cells results also in dephosphorylation of Ser10 of β4-myc-associated histone H3 
(Supplementary Figure 9c). ChIPs experiments using anti-HP1γ antibodies demonstrate 
the association of HP1γ to the TH promoter (Figure 7l). The strong decrease of this 
association in lh brain illustrates the role of β4 in recruiting HP1γ to the TH gene. Finally, 
double mutation of the HP1γ binding motif of β4 precludes the B56δ-dependent 
interaction of β4 with histone H3 demonstrating that HP1γ or HP1γ-like proteins are 
required for β4 association to histones (Figure 7m). 
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β4-dependent TH gene repression is mediated by electrical activity  
Our results indicate that in neurons there should be a β4-dependent coupling between 
electrical activity and TH gene repression. To validate this conclusion, the electrical 
activity-dependence of TH mRNA levels was investigated using cerebellar granule 
neurons from wt and lh mice. Because these cells required depolarizing conditions to 
survive (25 mM KCl), which promotes basal level electrical activity, our control 
condition was defined as TH mRNA level after 2 days of TTX treatment (from 8 DIV to 
10 DIV). Promoting electrical activity for one day, by removing TTX from 9 DIV to 10 
DIV, induces strong TH mRNA level repression in wt (50%) but not in lh neurons 
(Figure 8a).                                                                                                                                                           
 
Discussion 
Here, we characterized a novel signaling pathway in which, under membrane 
depolarization, the VGCC β4 subunit accumulates in the nucleus and acquires a gene 
regulatory function by successively recruiting the B56δ/PP2A complex, a transcription 
factor and the heterochromatin protein HP1γ. Nuclear localization of β4 was previously 
shown in mice brain by Subramanyam and coll. (Subramanyam et al, 2009). In contrast 
to what we observe with endogenous β4, these authors show that depolarization of 
cultured neurons expressing V5-tagged β4 promotes nuclear export of the tagged protein. 
Besides the possibility that the V5 tag may interfere with the β4 / B56δ interaction we 
describe and thus modify β4 nuclear targeting pathways, these results may highlight an 
active equilibrium between different pathways of β4 nuclear import and export. This 
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group identified the N-terminus of β4 as a possible determinant of nuclear accumulation. 
In support with the previous hypothesis, our own results show that this domain only 
partially interferes with β4 nuclear accumulation suggesting the existence of different 
pathways controlling β4 subcellular localization involving different β4 protein partners. 
We demonstrate here that the N-terminus of β4 is not important for its interaction with 
B56δ suggesting that its contribution to nuclear accumulation occurs through a B56δ-
independent pathway. In our work, we focused on the β4 nuclear pathway that involves 
B56d and that is disrupted by the human epileptic mutation of β4. We show that in vitro 
TRα acts as a transcription factor capable to interact with β4 and repress TH gene 
expression. The in vivo implication of TRa in controlling TH gene expression remains to 
be deciphered. The resulting nuclear platform, structured by β4, binds to specific gene 
promoters, dephosphorylates histones associated to these promoters and orients HP1γ 
interaction with the dephosphorylated histones. The formation of this complex allows 
gene repression, first by a direct effect of β4 on TRα, and secondly by HP1γ recruitment 
known to promote heterochromatin formation (Figure 8b). This later step may lead to 
long-term gene repression, while the first step is conceptually more dynamic. In lh brain, 
a complete disorganization of this signaling pathway is observed in the absence of β4. 
The combined reduction in HP1γ levels and greater phosphorylation level of histone H3 
Ser10, are two events that conceptually may favor the up-regulation of TH expression. In 
that respect, further studies on the ability of nuclear β4 complex to induce other histone 
post-translational modifications, such as methylation or acetylation, will complete the 
characterization of the role of this complex in gene regulation. While our data 
demonstrate the key role of β4 in organizing TH gene repression, TH expression is not 
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uniformly up-regulated in all lh brain areas indicating the existence of compensatory 
mechanisms. In that respect, B56γ, that also targets PP2A to the nucleus (McCright et al, 
1996), and β3, another VGCC subunit, that is also addressed to the nucleus (Beguin et al, 
2006) and binds B56δ (Figure 4c) and TRα (unpublished observation), might participate 
to this compensation process. The juvenile epilepsy mutant that normally associates with 
VGCC (Escayg et al, 2000), is defective for B56δ association. This mutant no longer 
forms a complex with PP2A, and is unable to translocate to the nucleus and to interact 
with HP1γ and histones (Figure 8b). Therefore, this mutation induces a full 
destabilization of the β4 signaling pathway. At the structural level, formation of the 
B56δ/β4 complex requires the interaction between the β4 SH3 and GK modules. The 
nuclear targeting defect induced by the human mutation resides in the loss of this 
interaction highlighting an unexpected role of β4 C-terminal domain in controlling β4 
conformation state. Association of B56δ with β4 promotes β4/HP1γ interaction further 
indicating the exquisite modularity of β4 as an adaptor protein. 
In earlier reports, B56δ/PP2A was shown to regulate gene expression through a 
complex interplay between DARPP-32 phosphorylation state (Ahn et al, 2007), 
phosphatase 1 (PP1) activity, and histone H3 phosphorylation level (Stipanovich et al, 
2008). PP1 complexes have been associated to other histone-modifying enzymes, such as 
histone deacetylases or kinases, with chromatin remodeling capabilities (Hsu et al, 2000; 
Murnion et al, 2001) and with transcription repressors or activators (Canettieri et al, 
2003; Jin et al, 2003). Here, we illustrate that, like PP1, PP2A belongs to a signaling 
macromolecular complex which ultimately regulates gene expression by modulating the 
histone code. This complex is organized by the VGCC β4 subunit that plays the role of a 
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platform that, besides PP2A, also recruits a nuclear receptor and a heterochromatin 
protein, HP1γ. By homology with PP1, this protein complex is likely to be enriched by 
other nucleosome-modifying enzymes in the near future. It should be emphasized that 
long-term modifications accompanying epileptic disorders have previously been 
associated to changes in post-translational state of histones and to alterations in 
transcriptional programs (Huang et al, 2002; Sng et al, 2006). This work thus opens 
exciting perspectives for understanding the underlying molecular causes of epilepsy in 
which VGCC subunits have been implicated. 
 
Material and Methods 
Mice lines 
Lethargic (B6EiC3H-a/A-lh) and wild-type mice (strain B6EiC3H) were obtained from 
Jackson Labs and genotyped as previously described (Burgess et al, 1997). B56δ-/- mice 
were generated by exchanging 146 bp of exon 3, exons 4 to 14, and 45 bp of exon 15 of 
the Ppp2r5d gene with a neomycine cassette through homologous recombination (Louis 
et al, 2011). Animal procedures were run with the approval of the local ethical committee 
and all efforts were made to minimize both the suffering and number of animal used. 
Also, the experiments were carried out in accordance with the International Ethical 
Committee Guidelines (EEC Council Directive 86/609, OJ L 358, 1, Dec. 12, 1987; 
Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 
1996) for the care and use of laboratory animals.  
 
Electron microscopy 
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Mice were fixed by intracardiac perfusion during 10 minutes with 50 ml of fixation 
buffer (2% paraformaldehyde, 0.2% glutaraldehyde in 0.1 M phosphate buffer pH 7.3). 
The hippocampus was then isolated and kept in fixation buffer during 2 days. A 
transversal slice was made in the mid third of the hippocampus and dissection of the 
CA1/CA3 area in this slice was performed under a binocular magnifier. Hippocampal 
neurons were cultured in B100 plates during 5 or 18 days and fixed 2 hrs with fixation 
buffer. Cells were gently detached with a cell scraper, centrifuged and embedded in 10% 
gelatine. The cell pellet was then cut in small pieces. 1 mm3 cell or tissue samples were 
then incubated during 4 hrs in 2.3 M sucrose and frozen in liquid nitrogen. Cryosections 
were made at -120°C using a cryo-ultramicrotome (Leica-Reichert) and retrieved with a 
1:1 solution of 2.3 M sucrose and 2% methylcellulose (Liou et al, 1996). Cryosections 
were first incubated with primary anti-β4 (Everest Biotech, 1:100), then incubated with 
rabbit anti-goat antibodies (Jackson, 1:400) and revealed with protein A-gold conjugated 
(CMC, Utrecht). Labelled cryosections were viewed at 80 kV with a 1200EX JEOL TEM 
microscope and images were acquired with a digital camera (Veleta, SIS, Olympus). 
Gold particles were counted and surface area measured with iTEM software (analySIS). 
 
Hippocampal neurons, NG108-15 cell cultures and cerebellar granule neurons 
Primary cultures of hippocampal neurons were prepared as previously described (Peris et 
al, 2009). Astrocyte proliferation was blocked by 10 µM arabinoside cytosine (AraC) 
four days after plating. Predominance of neurons was witnessed by Tuj1 labeling and 
lack of GFAP staining. NG108.15 cells were differentiated two days after plating by 
decreasing fetal calf serum to 1% and addition of 1 mM dibutyryl cAMP. Cell lines were 
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transfected using jetPEI and neurons at 9 DIV using calcium phosphate. Dissociated 
cerebellar granule neurons were prepared as previously described (Kiyonaka et al, 2007) 
except that 0.02% (w/v) trypsin (Difco) was used for dissociation of cerebellar tissues. 
Three hrs after cell plating, culture medium was replaced with Neurobasal (Invitrogen) 
with 2% B-27 (GIBCO), 26 mM KCl, 60 U/ml penicillin, and 60 μg/ml streptomycin, 
and renewed every 3 days. At 8 DIV, 0.1 μM TTX was added in the culture medium to 
block electrical activity. At 9 DIV, the TTX was washed out to promote electrical activity 
or maintained for continued electrical activity block. At 10 DIV, total RNA was isolated 
using NucleoSpin RNA XS (Macherey-Nagel) according to the manufacturer’s 
instructions. 
 
Plasmid constructions 
cDNA constructs coding for EGFP-tagged β4 fragments were generated by PCR 
amplification using rat β4-EGFP plasmid as template (Genbank accession code L02315) 
and subcloned into pEGFP-C1 using HindIII and KpnI sites. Myc-tagged β4 fragments 
were subcloned into pcDNA3.1(+) using HindIII and XbaI sites. For yeast two-hybrid 
assays, rat β1, β2, β3, β4, and β4 mutants were subcloned into pGBK-T7 vector(Kiyonaka 
et al, 2007). QuikChange® Site-Directed Mutagenesis Kit (Stratagene) or overlap 
extension method was used to produce βL125P-EGFP, βP225R-EGFP, β1-166-L125P-EGFP, 
βP220A-V222A-myc and βR28A-R29A-S30A-EGFP. Mouse B56δ (Genbank accession code 
NM009358), HP1γ (NM_007624) and TRα (NM_178060) were cloned from mouse 
brain Marathon-Ready cDNA (Clontech) using PCR and inserted into pCMV-tag3 vector 
and pEGFP-C2 vector using EcoRI and SalI site. The B56δ and control shRNAs (sense 
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strand sequences: 5’-CATCGCATCTATGGCAAGTTT-3’ and 5’-
CAACAAGATGAAGAGCACCAA-3’, respectively) were subcloned in TRC1.5 vector 
(Sigma). All constructs were sequenced. Human Cacna1a (Genbank accession code 
AF004883) and rat Cacna1a (code NM012919) were also used for expression 
experiments. The TH-luciferase reporter gene was as previously described (Robert et al, 
1997) and contains 5,200 bps of the TH promoter upstream of the Firefly luciferase 
coding region. 
 
Cytochemical stainings 
Cells were fixed with 4% paraformaldehyde in PBS for 15 min. After PBS washing, 
plasma membranes were stained 5 min with 5 µg/ml concanavalin A-rhodamine. Cells 
were permeabilized with 0.1% Triton X-100. Myc-tagged constructs were visualized 
using biotinylated anti-myc antibodies (1:600, Santa Cruz) and Cy3-Streptavidin (1:300, 
Amersham). Endogenous β4 was labeled for 1-2 hrs with a goat antibody directed against 
its carboxyl-terminus (1/1,000 dilution, Everest Biotech), followed by Alexa488 
conjugated anti-goat (1:500, Molecular Probes). Cell nuclei were visualized using ToPro3 
dye (T3605; Molecular Probes Inc). Images were obtained with a confocal microscope 
(Leica SP2). NCR values correspond to the average measure of 50 cells. In each cell, 
fluorescence intensities were measured in forty different ROI (20 for the cytoplasm and 
20 for the nucleus). Merged pictures were obtained by using Adobe Photoshop software. 
 
Yeast two hybrid assays 
Rat β4, subcloned into pGBK-T7, was used as bait to screen a mouse brain pACT2 library 
expressed in the yeast strain AH109 (Clontech) (Kiyonaka et al, 2007). 5.0 x 106 
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transformants were cultured with synthetic medium lacking adenine, histidine, leucine, 
and tryptophan. His+ colonies were assayed in yeast cells for β-galactosidase activity by a 
filter assay. Signal strengths of interactions were evaluated visually after every 1 hr of 
color development. For mapping of the β4 region that interacts with B56δ or HP1γ, yeast 
strain Y187 was co-transformed with each β bait vector and the B56δ or HP1γ prey 
vector. The interactions were evaluated by β-galactosidase activity on a filter. 
 
Subcellular fractionation and Western blotting 
Transfected HEK293 cells were lysed with 10 mM Tris pH 7.5, 10 mM KCl, 1.5 mM 
MgCl2, 0.5% Triton X-100 and protease inhibitor cocktail (Roche). Nuclei and cytoplasm 
were separated by 5 min centrifugation at 2,000 rpm. Pellets corresponding to nuclei 
were sonicated in lysis buffer. For mice brain subcellular fractionation, brains were 
homogeneized in 0.32 M sucrose, 20 mM HEPES, pH 7.4, 1 mM DTT, 1 mM PMSF and 
protease inhibitor cocktail (Roche). The homogeneate was centrifuged 10 min at 800×g. 
The resulting crude nuclear pellet was washed twice with homogeneization buffer, 
resuspended in a volume equivalent to the cytoplasmic fraction, and sonicated. Nuclear 
and cytoplasmic (supernatant) proteins, from equal volumes, were separated by SDS-
PAGE and analyzed by Western blot. EGFP tagged-proteins were visualized using anti-
EGFP antibodies (1:300, Santa Cruz or 1:5,000 Rockland) and anti-β4 as described 
(Kiyonaka et al, 2007). 
 
Immunoprecipitation experiments 
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Transfected cells were lysed 30 min in 10 mM Tris pH 7.4, 1.5 mM MgCl2, 60 mM KCl, 
15 mM NaCl, 0.5% Triton X-100 supplemented with protease inhibitor cocktail (Roche), 
sonicated and centrifuged 5 min at 1,500×g. Similar procedure applies for mice brain, 
except that they were homogeneized first in lysis buffer. Protein extracts were incubated 
with streptavidin beads (Dynabeads® Streptavidin M-280, Dynal) precoated with 3 μg of 
biotinylated anti-myc antibody (Santa Cruz Biotechnology Inc.). For 
immunoprecipitation of endogenous β4, protein extracts were incubated with 40 µl of 
dynabeads® protein G (Dynal) precoated with anti-β4 antibodies (Everest Biotech). 
Beads were washed with PBS/0.1% Tween 20. Immunoprecipitated proteins were eluted 
with denaturating buffer and analyzed by Western blot. For immunoprecipitation of 
phosphorylated histones, lysis buffer was supplemented with 50 mM NaF phosphatase 
inhibitor. For immunoprecipitation and ChIP, primary antibodies were used at 10 µg: 
anti-β4 from Everest or as described (Kiyonaka et al, 2007), anti-histone H2B from 
Upstate, anti-histone H3, anti-phosphorylated Ser10 histone H3, anti-histone H4, anti-
HP1γ, and anti-TRα from Abcam, anti-B56δ as described in(Martens et al, 2004), anti-
PP2A from Bethyl laboratories Inc., and anti-actin from Sigma-Aldrich. 
 
PP2A activity 
PP2A activity of immunoprecipitates was measured using SensoLyte™pNPP protein 
phosphatase kit from AnaSpec. Incubation lasted 1 hr at 37°C in assay buffer in the 
presence of p-nitrophenyl phosphate (pNPP). OD was measured at 405 nm. 
 
Quantitative RT-PCR 
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Total RNAs were extracted from wt, lh or B56δ-/- cerebellum using the RNeasy kit, 
supplemented with DNase I (Qiagen). cDNAs were synthesized from 1 µg total RNA 
using random hexamer primers (Promega) and Superscript II (Invitrogen). Primers 
recognizing mice sequences were designed with the Primer 3 software 
(http://frodo.wi.mit.edu/) or by Sigma service (Supplementary Figure 10). Real time PCR 
was performed with a light cycler 480 instrument using the Lightcycler LC480 SYBR 
green I master (Roche) according to the manufacturer’s instructions. The cycling protocol 
was 10 min at 95°C followed by 40 cycles of 3 steps each (10 sec at 95°C, 5 sec at 60°C, 
and 10 sec at 72°C). The specificity of the amplification was check by generating a 
melting curve ranging from 65 to 95°C. Multiple normalization of gene expression 
(Vandesompele et al, 2002) was performed using 3 housekeeping genes (glyceraldehyde 
3-phosphate dehydrogenase, transferin receptor, and peptidylprolyl isomerase A). 
For TH expression levels in cerebellar granule neurons, cDNAs were synthesized using 
AMV reverse transcriptase XL and an oligo dT-adaptor primer (TaKaRa). Real time PCR 
and cycling protocol were performed as above, except for the number of cycles (50). TH 
gene expression was normalized relative to rpl27 (de Jonge et al, 2007). Values were 
expressed relative to wt treated with TTX, which was given the arbitrary value of 1.  
 
Chromatin immunoprecipitation 
Frozen adult mice brain (wt, lh or B56δ-/-) brain were first crunched into powder in a 
mortar filled with liquid nitrogen. This powder was resuspended in 1% formaldehyde (in 
PBS) and incubated for 20 min at RT. Cross linking was stopped by addition of glycine 
(125 mM final concentration) and incubation 5 min. Fixed tissues were thus washed with 
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i) cold PBS (5 min), ii) 10 mM HEPES, 0.5 mM EGTA, 10 mM EDTA and Triton X-100 
0.25%, pH 7.4 (10 min), and iii) 10 mM HEPES, 0.5 mM EGTA, 1 mM EDTA and 200 
mM NaCl, pH 7.4 (10 min). Samples were then solubilized in 1 ml of buffer containing 
50 mM Tris, pH 7.4, 10 mM EDTA, 1% SDS for 2 hrs at 4°C, sonicated until reaching an 
average 500-1,000 bps DNA fragment size, and centrifuged 5 min at 20,000 g. 100 µl of 
lysate (DO280 = 0.266) were incubated overnight at 4°C in 1 ml of 0.01% SDS, 1.1% 
Triton X100, 1.2 mM EDTA, 16 mM Tris pH 8.0 and 170 mM NaCl, 1 mM PMSF, and 
protease inhibitor cocktail, with or without 10 µg antibodies. Immunoprecipitation was 
performed by adding dynabeads protein G (Invitrogen). Different washing steps and 
elution were performed as described (Dahl & Collas, 2008). Cross-links were reversed 
overnight at 65°C. DNA samples were sequentially treated with RNAse A and proteinase 
K. DNA was extracted by phenol/chloroform and ethanol precipitated with glycogen as a 
carrier. DNA pellet was dissolved in water and real-time quantitative PCR analyses were 
performed on 25 ng of DNA in duplicate with selected primers (Supplementary Figure 
10). On cultured hippocampal neurons, ChIP experiments were conducted on 5×106 cells 
using the Magna ChIPTM (MILLIPORE) according to the manufacture’s protocol. The 
PCR cycling protocol was 10 min at 94°C followed by 38 cycles of 3 steps each (30 sec 
at 94°C, 30 sec at 55°C or 61°C, and 30 sec at 72°C), and 7 min at 72°C. Annealing 
temperature for the promoter region of TH was 55°C and for the 3’UTR of TH was 61°C. 
 
Mass spectrometry 
The histone H3 peptide phosphorylated at Ser10 QTARKSpTGGC was obtained from 
Smartox biotechnologies (Grenoble, France). Immunoprecipitates were washed with (in 
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mM) 40 Tris pH 8.4, 34 MgCl2, 4 EDTA, 4 DTT, and incubated overnight at 37°C with 1 
mM peptide. Dephosphorylation was evaluated by MALDI-TOF (Applied 4800) mass 
spectrometry. Briefly, 1 µl of peptide solution was spotted directly onto the MALDI 
target, dried and 1 μl of 20% α-Cyano-4-hydroxy-cinnamic acid (Sigma) was added in 
50% acetonitril, 0.1% trifluoracetic acid. 
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Figure legends 
 
Figure 1 Presence of β4 in the nucleus of neurons. (a) Immunohistochemical confocal 
images of 20 µm coronal sections of adult wt (upper panels) or lh (lower panels) mice 
brains showing the distribution of endogenous β4 in the dentate gyrus (green, left panels). 
Neuronal nuclei were labeled with NeuN (blue, middle panels). Right panels illustrate 
merged images. The inserts show 5X images of the CA3 region (initially 20X). (b) 
Western blots of adult wt and lh mice brain lysates indicating the presence of β4 only in 
wt mice. Actin staining was used as an internal control. (c) β4 immunoblotting from 
cytoplasmic and nuclear fractions of adult wt mice brain. β-tubulin and nucleolin are used 
as indicators of nuclear and cytoplasmic fraction purities, respectively. (d) EM image of 
an ultrathin cryosection of the CA1 hippocampal region showing the intranuclear 
presence of β4 labelled with antibody-coated 15 nm gold particles. Black and white 
arrows indicate the position of gold particles associated to heterochromatin and 
euchromatin, respectively. (e) Confocal images of hippocampal neurons from embryonic 
E18 mice brains in primary culture at 5 DIV (left panels) and 18 DIV (right panels). 
Green: immunocytochemical staining of β4; red: membrane staining with concanavalin A 
(ConA) conjugated to rhodamine; blue: nuclear staining with ToPro3. (f) DIV-dependent 
evolution of β4 NCR values in neurons (n=50 cells for each data point). (g) Nuclear 
density of β4 in hippocampal neurons at 5 and 18 DIV as assessed by EM (n=28 and 20 
nuclei, respectively). (h) Confocal images of NG108.15 cells 1 day before (-1 DIV) and 
13 days (13 DIV) after induction of neuronal differentiation with 1 mM cAMP and serum 
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reduction. Color code is as in (e). Differentiated NG108-15 cells have larger nuclei than 
non-differentiated cells. (i) Mean NCR values expressed in percent as a function of 
culture time in vitro. DIV 0 represents the induction time of neuronal differentiation. 
 
Figure 2 Nuclear targeting and structural integrity of β4 are disrupted by the human 
juvenile epilepsy mutation. (a) Schematic representation of different truncated β4 
constructs in pEGFP-C1. The β1-481-EGFP mutant is also shown. (b) Confocal images of 
CHO cells expressing some representative constructs, including β4-EGFP and mutant β1-
481-EGFP. Expression time is 24 hrs after transfection. (c) Mean NCR values of EGFP 
fluorescence for each condition in transfected CHO cells. ***, p ≤ 0.01. (d) Western blot 
detecting EGFP in nuclear and cytoplasmic fractions of CHO cells after two days of 
transfection with EGFP, β4-EGFP or β1-481-EGFP. Cytoplasmic β1-481-EGFP is less stable 
than cytoplasmic β4-EGFP, as witnessed by the presence of lower molecular weight 
bands. These truncated constructs are deficient in nuclear accumulation as shown in (c), 
possibly because containing GK domains. (e) Confocal images of hippocampal neurones 
transfected at 7 DIV with β1-481-EGFP (upper panels) or β4-EGFP (lower panels). Images 
were acquired at 9 DIV on β-tubulin III-positive cells. (f) NCR values for each construct. 
***, p ≤ 0.01. (g) Confocal images of hippocampal neurons transfected with β1-481-EGFP 
showing the comparative distribution of endogenous β4 (red) and exogenous β1-481-EGFP 
(green).  
 
Figure 3 The SH3/GK interaction is required for β4 nuclear localization. (a) EGFP- or 
myc-tagged β4-truncated constructs used for confocal microscopy and co-
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immunoprecipitation experiments. (b) Confocal images of CHO cells transfected with 
individual constructs. (c) Confocal images of CHO cells expressing β1-166-EGFP with 
β200-519-myc, or β1-166-EGFP with β200-481-myc (upper panels). Mean NCR values of 
EGFP or anti-myc fluorescence summarizing the effect of the co-expressions on nuclear 
localization (lower panels). ***, p ≤ 0.001. (d) Immunoprecipation experiments in CHO 
cells investigating the association of β1-166-EGFP with β200-519-myc or β200-481-myc. Left 
panel: immunoprecipitation via anti-myc antibodies and Western blot of EGFP, except 
first lane showing β4-EGFP expression level in cell lysates. Right panel: Western blot 
with polyclonal anti-β antibody (Bichet et al, 2000) indicating equivalent β200-519-myc 
and β200-481-myc immunoprecipitation levels. β1-166-EGFP expression confirmed by cell 
EGFP fluorescence. (e) Schematic representation of βL125P-EGFP, β1-166-L125P-EGFP and 
βP225R-EGFP mutants. (f) Lack of co-immunoprecipation shows the absence of β200-519-
myc/β1-166-L125P-EGFP interaction. Expression of β1-166-EGFP and β200-519-myc was 
verified by the cell fluorescence and Western blot as in (d). (g) Confocal images of 
hippocampal neurons showing the cytoplasmic localization of βL125P-EGFP and βP225R-
EGFP. Cells were transfected for 48 hrs at 6 DIV. (h) Mean NCR values for β4-EGFP, 
βL125P-EGFP and βP225R-EGFP fluorescence in hippocampal neurons. ***, p ≤ 0.001. 
 
Figure 4 B56δ/β4 interaction contributes to β4 nuclear localization. (a) Yeast two hybrid 
results indicating the interaction level of β4 and β1-481 with B56δ as a function of time 
(left). The interactions were scored as the ratio of β-galactosidase activity to His 
prototrophy. Schematic representation of mouse B56δ showing the NLS amino acid 
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sequence (right). The position of seven HEAT repeats are shown by homology with 
B56γ (Magnusdottir et al, 2009). (b) Co-immunoprecipation experiments determining the 
interaction between β4-EGFP or β1-481-EGFP with B56δ-myc in HEK293 cells. Left 
panel: expression of B56δ-myc was confirmed by Western blot (Mr 69 kDa). Right 
panel: pull-down with anti-myc antibody, and Western blot with anti-EGFP antibody. (c) 
Interactions of β isoforms with B56δ and HP1γ in yeast two hybrid assay. (d) Interactions 
of truncated and mutated β4 constructs with B56δ using yeast two hybrid assay. (e) Effect 
of B56δ shRNA and control shRNA on the NCR value of β4-EGFP in CHO cells. ***, p 
≤ 0.001; NS, p ≥ 0.1. (f) Effect of B56δ shRNA and control shRNA on the nuclear / 
cytoplasmic distribution of β4-EGFP in CHO cells, as assessed by WB. Histone H3 and 
β-tubulin are used as markers of the nucleus (N) and cytoplasm (C), respectively. 
Performed in duplicate. Average ratios of 4.2 ± 0.32 (β4-EGFP) and 0.97 ± 0.81 (β4-
EGFP + shRNA B56δ). (g) Confocal images showing the cell distribution of endogenous 
β4 in undifferentiated NG108.15 cells in the absence or presence of B56δ-myc (left 
panels). B56δ-myc was transfected 24 hrs before confocal imaging. Panels in green 
present the endogenous β4 detected with an anti-β4. Mean NCR values showing that 
B56δ-myc induces the redistribution of endogenous β4 to the nucleus (right panel). ***, p 
≤ 0.001. (h) Mean NCR values of endogenous β4 from wt and B56δ-/- hippocampal 
neurons at 11 DIV. ***, p ≤ 0.001. (i) Average immunogold-labeled endogenous β4 in 
nuclei from pyramidal neurons from wt and B56δ-/- mice hippocampus measured by EM 
(n=36 and 51 nuclei, respectively). ***, p ≤ 0.001. Control counts in lh hippocampus 
were 0.51 ± 0.36 gold particles/µm². 
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Figure 5 β4 association to B56δ/PP2A is inhibited by channel expression and activated 
by membrane depolarization. (a) β4 immunoprecipitates B56δ and PP2A from wt mice 
brain but not from lh or B56δ-/- mice as shown by Western blots. (b) Left panel: 
immunoprecipitation of endogenous PP2A by B56δ-myc or β4-myc ± B56δ-EGFP 
expressed in HEK293 cells. Right panel: similar experiments using β1-481-myc ± B56δ-
EGFP. (c) Endogenous PP2A phosphatase activity associated to immunoprecipitated β4-
myc ± B56δ-EGFP expressed in HEK293 cells. Dephosphorylation of p-nitrophenyl 
phosphate (pNPP), a generic phosphatase substrate, was measured by absorbance of the 
metabolite at 405 nm. Experiment in duplicate. (d) Confocal images of HEK293 cells 2 
days after transfection with β4-EGFP together with Cacna1a and Cacna2d2 subunits 
(VGCC) (left panel). Mean NCR values of EGFP fluorescence in various transfection 
conditions (n=50 for each condition, right panel). (e) Western blot analysis of β4-EGFP 
subunit immunoprecipitated by B56δ-myc ± VGCC expressed in HEK293 cells. Control 
IP represents precipitation in absence of anti-myc antibodies. (f) Western blot analysis of 
B56δ-EGFP immunoprecipitated by β4-myc (left panels) or β1-481-myc (right panels) 
expressed in HEK293 cells together with VGCC, without or with a 30 min depolarization 
by 140 mM KCl. (g) Effect of HEK293 membrane depolarization (140 mM KCl, 30 min) 
on β4-myc or β1-481-myc complex formation with PP2A in the presence of B56δ-EGFP 
and VGCC. (h) Mean NCR values of β4 immunofluorescence in wt or B56δ-/- 
hippocampal neurons at 18 DIV (control or 1 µM TTX). TTX was added at 11 DIV in the 
culture media (n=50 for each condition). (i) Effect of a 1 hr application of 40 µM 
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biccuculine and 400 µM 4-AP on average β4 NCR value in wt and B56δ-/- hippocampal 
neurons. NS, non significant; ***, p<0.001. 
 
Figure 6 β4 regulates gene expression by interacting with a transcription factor. (a) 
Histogram showing up-regulated (in red) and down-regulated (in green) genes displaying 
a > 2-fold change in lh versus wt cerebellum mRNA levels as detected with 
transcriptomic probe sets. (b) qRT-PCR experiments showing up-regulation of TH, 
TAC1, KLB and down-regulation of BC031748 and RIF1 in lh versus wt cerebellum. 
Mean ± S.D. of 3 experiments performed in triplicate. Data were normalized using 3 
housekeeping genes (glyceraldehyde 3-phosphate dehydrogenase, transferin receptor, and 
peptidylprolyl isomerase A). (c) Agarose gel of representative ChIP assay on 
hippocampal neurons at 1 or 18 DIV with anti-β4 antibodies. (d) TH promoter 
immunoprecipitation in presence or absence (control) of anti-β4 antibodies, expressed as 
percentage of input, from wt or lh mice brain (n=4-22, left panel). ***, p<0.001. (e) 
Yeast two hybrid results indicating the interaction level of β4 with TRα as a function of 
time (upper panel). The interactions were scored as the ratio of β-galactosidase activity to 
His prototrophy. Schematic representation of mouse TRα showing the localization of the 
DNA Binding Domain (DBD) and the Ligand Binding Domain (LBD) (lower panel). (f) 
Western blot analysis of TRα-EGFP immunoprecipitated by β4-myc expressed in 
HEK293 cells. (g) TH promoter immunoprecipitation by anti-TRα antibodies, expressed 
as percentage of input, from wt, lh or B56δ-/- mice brain (n=4-20, left panel). ***, 
p<0.001. (h) Schematic representation of the luciferase reporter system under the control 
of TH promoter (upper panel). Luciferase expression measured in the absence and 
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presence of T3 in HEK293 cells transfected with the luciferase reporter alone or together 
with TRα ± β4 (lower panel). An everted repeat type 6 TRE is present in the promoter 
region of TH gene (TGGCCTTGCCTGAGGCCA) at position -341 to -323. 
 
Figure 7 Association of β4 to HP1γ and histones requires B56δ. (a) TH promoter 
immunoprecipitation by anti-B56δ antibodies, expressed as percentage of input, from wt, 
lh or B56δ-/- mice brain (n=2-8). **, p<0.05. (b) TH promoter immunoprecipitation by 
anti-PP2A antibodies, expressed as percentage of input, from wt mice brain (n=12). **, 
p<0.05. (c) Western blot of H3 and H3 Ser10P in HEK293 cells expressing β4-myc alone 
or with B56δ-EGFP. (d) Mass spectrometry data showing dephosphorylation of the 
phosphorylated N-terminal histone H3 peptide (amino acids 5 to 13 phosphorylated on 
Ser10) by β4-myc immunoprecipitated from HEK293 cells, cotransfected with B56δ-
EGFP and PP2A-HA. (e) TH promoter immunoprecipitation by anti-Ser10P H3 or anti-H3 
antibodies, expressed as percentage of input, from wt or lh mice brain (n=3-22). *, p<0.1. 
(f) Schematic representation of β4c and β4 illustrating the localization of the HP1γ binding 
motif (critical residues are shadowed). (g) Western blot of HP1γ-EGFP following 
immunoprecipitation by anti-myc antibodies from HEK293 cells expressing various 
combinations of HP1γ-EGFP, B56δ-EGFP and β4-myc. (h) Immunoprecipitation of 
histone H3 from wt, lh or B56δ-/- brain by anti-β4 antibodies. (i) Immunoprecipitation of 
H3, H2B and H4 histones from HEK293 cells by β4-myc in the absence or presence of 
B56δ-EGFP. Control: immunoprecipitation in non-transfected cells (NT). (j) 
Immunoprecipitation of histone H3 in HEK293 cells by B56δ-myc in the absence or 
presence of β4-EGFP. (k) Lack of co-immunoprecipitation of histone H4 and B56δ-myc 
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in HEK293 cells in the presence of βL125P-EGFP or β1-481-EGFP mutants. (l) TH promoter 
immunoprecipitation by anti-HP1γ antibodies, expressed as percentage of input, from wt 
or lh mice brain (n=4-14). **, p<0.05. (m) Mutation of the HP1γ binding motif prevents 
β4-myc association to histone H3 in the presence of B56δ-EGFP. 
 
Figure 8 Experimental validation and schematic illustration of the novel excitation-
transcription pathway mediated by β4. (a) Electrical activity reduces TH mRNA levels in 
primary cultures of cerebellar granule neuronal from wt mice but not lh mice. Upper 
panel represents the experimental protocol. First condition in which TTX is added for 2 
days (8 DIV to 10 DIV) is used as control condition without electrical activity (blue 
colour), whereas second condition in which TTX is washed out at 9 DIV is used as the 
condition in which electrical activity is restored (red colour). Lower panel illustrates the 
fold-change in TH mRNA level induced by electrical activity using rpl27 as 
housekeeping gene and normalisation to control condition. **, p<0.05. (b) Schematic 
representation of the new signalling pathway and of the defective steps produced by the 
epileptic truncation of β4. 
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